Schutzimpfungen in medizinischen Einrichtungen

• Literatur

• 1 Pletz MW, Zanger P, Jilg W et al. Impfungen. Dtsch Med Wochenschr 2011; 136: 2011-2015
• 2 Hellenbrand W, Beier D, Jensen E et al. The epidemiology of pertussis in Germany: past and present. BMC Infect Dis 2009; 9: 22 [PMID: 19243604]
• 3 Otto W, Mankertz A, Santibanez S et al. Ongoing outbreak of mumps affecting adolescents and young adults in Bavaria, Germany, August to October 2010. Euro Surveill 2010; 15 pii 19748
• 4 RKI. Influenza-assoziierte Mortalität in Deutschland 1985–2006. Epidem Bull 2007; Nr. 35: 325-327
• 5 STIKO. Erweiterung der beruflichen Indikation für eine Pertussisimpfung. Epidem Bull 2009; 31: 299-311
• 6 STIKO. Änderung der Empfehlung zur Impfung gegen Masern. Epidem Bull 2010; 32: 315-322
• 7 Averhoff F, Mahoney F, Coleman P et al. Immunogenicity of hepatitis B vaccines. Implications for persons at occupational risk of hepatitis B virus infection.. Am J Prev Med 1998; 15: 1-8
• 8 Leuridan E, Van Damme P. Hepatitis B and the need for a booster dose. Clin Infect Dis 2011; 53: 68-75
• 9 Farez MF, Correale J. Immunizations and risk of multiple sclerosis: systematic review and meta-analysis. J Neurol 2011; 258: 1197-206
• 10 Carman WF, Elder AG, Wallace LA et al. Effects of influenza vaccination of health-care workers on mortality of elderly people in long-term care: a randomised controlled trial. Lancet 2000; 355: 93-97
• 11 Maltezou HC, Drancourt M. Nosocomial influenza in children. J Hosp Infect 2003; 55: 83-91
• 12 Vanhems P, Voirin N, Roche S et al. Risk of influenza-like illness in an acute health care setting during community influenza epidemics in 2004–2005, 2005–2006, and 2006–2007: a prospective study. Arch Intern Med 2011; 171: 151-157
• 13 Ehrenstein BP, Hanses F, Blaas S et al. Perceived risks of adverse effects and influenza vaccination: a survey of hospital employees. Eur J Public Health 2010; 20: 495-499
• 14 Wicker S, Rabenau HF, Kempf VA et al. Vaccination against classical influenza in health-care workers: self-protection and patient protection. Dtsch Arztebl Int 2009; 106: 567-72
• 15 Michiels B, Govaerts F, Remmen R et al. A systematic review of the evidence on the effectiveness and risks of inactivated influenza vaccines in different target groups. Vaccine 2011; 29: 9159-9170
• 16 Lasky T, Terracciano GJ, Magder L et al. The Guillain-Barré syndrome and the 1992–1993 and 1993–1994 influenza vaccines. N Engl J Med 1998; 339: 1797-1802
• 17 Grimaldi-Bensouda L, Alpérovitch A, Besson G et al. for the GBS-PGRx Study Group Guillain-Barré syndrome, influenzalike illnesses, and influenza vaccination during seasons with and without circulating A/H1N1 viruses. Am J Epidemiol 2011; 174: 326-335
• 18 Liang XF, Li L, Liu DW et al. Safety of influenza A (H1N1) vaccine in postmarketing surveillance in China. N Engl J Med 2011; 364: 638-647
• 19 Heininger U. Pertussis immunisation in adolescents and adults. Adv Exp Med Biol 2008; 609: 72-97
• 20 Mankertz A, Mihneva Z, Gold H et al. Spread of measles virus D4-Hamburg, Europe, 2008–2011. Emerg Infect Dis 2011; 17: 1396-1401
• 21 World Health Organisation (WHO). Strategic plan for measles and congenital rubella infection in the WHO European Region. Copenhagen, Denmark: WHO Regional Office for Europe; 2003 Im Internet: http://www.euro.who.int/document/e81567.pdf (Stand 24.2.2012)
• 22 Strebel PM, Papania MJ, Dayan GH, Halsey NA. Measles vaccine. In: Plotkin SA, Orenstein WA, eds. Vaccines. Philadelphia: Elsevier; 2008: 353-398
• 23 Mrozek-Budzyn D, Kiełtyka A, Majewska R. Lack of association between measles-mumps-rubella vaccination and autism in children: a case-control study. Pediatr Infect Dis J 2010; 29: 397-400
• 24 Godlee F, Smith J, Marcovitch H. Wakefield's article linking MMR vaccine and autism was fraudulent. Br Med J 2011; 342: 7452
• 25 Faber MS, Stark K, Behnke SC et al. Epidemiology of hepatitis A virus infections, Germany, 2007–2008. Emerg Infect Dis 2009; 15: 1760-1768
• 26 Van Damme P, Banatvala J, Fay O. International Consensus Group on Hepatitis A Virus Immunity Hepatitis et al. A booster vaccination: is there a need? . Lancet 2003; 362: 1065-1071
• 27 Victor JC, Monto AS, Surdina TY et al. Hepatitis A vaccine versus immune globulin for postexposure prophylaxis. N Engl J Med 2007; 357: 1685-1694
• 28 RKI. Empfehlungen der Ständigen Impfkommission (STIKO) am Robert-Koch-Institut. Stand: Juli 2011. Epidem Bull 2011; 30: 275-294
• 29 Dayan GH, Quinlisk MP, Parker AA et al. Recent resurgence of mumps in the United States. N Engl J Med 2008; 358: 1580-1589
• 30 STIKO. Änderung der Empfehlungen zur Impfung gegen Röteln. Epidemiologisches Bulletin 2010; 32: 322-325
• 31 Reef SE, Strebel P, Dabbagh A et al. Progress toward control of rubella and prevention of congenital rubella syndrome – worldwide, 2009. J Infect Dis 2011; 204 (Suppl. 01) 24-27
• 32 Siedler A, Arndt U. Impact of the routine varicella vaccination programme on varicella epidemiology in Germany. Euro Surveill 2010; 15: 19530
• 33 Watson B. Humoral and cell mediated immune responses in children and adults after 1 and 2 doses of varicella vaccine. J Infect Dis 2008; 197: 143-146
• 34 Modlin JF. The bumpy road to polio eradication. N Engl J Med 2010; 362: 2346-2348
• 35 Plotkin SA, Vidor E. Poliovirus vaccine – inactivated. In: Plotkin SA, Orenstein WA, eds. Vaccines. 5th. ed. Philadelphia: Saunders; 2008: 605-629